Civic Intelligence

Hope Funds for Cancer Research

EIN 20-5799367 • 501(c)3 • Newport, RI

Newport, RI
Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

80th percentile

0.42x

Higher debt load relative to assets than 80% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2025

Liabilities / Revenue

83rd percentile

0.58x

Higher debt load relative to revenue than 83% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2025

Net Margin

71st percentile

18%

Higher net margin than 71% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2025

Top Officer Pay

40th percentile

$0

Higher top officer pay than 40% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • $1M-$5M nonprofits • Source year 2025

Asset Growth

84th percentile

30%

Faster asset growth than 84% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2024 to 2025

Revenue Growth

90th percentile

91%

Faster revenue growth than 90% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2024 to 2025

Assets

Up

$1,031,079

Up $140,372 (+16%) from 2022

Liabilities

Down

$399,799

Down $95,201 (-19%) from 2022

Net Assets

Up

$631,280

Up $235,573 (+60%) from 2022

Revenue

Up

$752,179

Up $435,209 (+137%) from 2022

Expenses

Up

$516,774

Up $247,778 (+92%) from 2022

Net Income

Up

$235,405

Up $187,431 (+391%) from 2022

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$3.0M$2.0M$1.0M$0Assets 2011: $853,665Liabilities 2011: $277,500Net Assets 2011: $576,1652011Assets 2012: $1,088,724Liabilities 2012: $519,400Net Assets 2012: $569,3242012Assets 2013: $1,283,819Liabilities 2013: $565,035Net Assets 2013: $718,7842013Assets 2014: $2,025,952Liabilities 2014: $853,497Net Assets 2014: $1,172,4552014Assets 2015: $2,233,328Liabilities 2015: $1,191,278Net Assets 2015: $1,042,0502015Assets 2016: $2,464,697Liabilities 2016: $794,278Net Assets 2016: $1,670,4192016Assets 2017: $2,549,665Liabilities 2017: $642,000Net Assets 2017: $1,907,6652017Assets 2018: $2,505,281Liabilities 2018: $588,500Net Assets 2018: $1,916,7812018Assets 2019: $2,531,035Liabilities 2019: $568,500Net Assets 2019: $1,962,5352019Assets 2020: $889,907Liabilities 2020: $493,500Net Assets 2020: $396,4072020Assets 2021: $971,860Liabilities 2021: $656,000Net Assets 2021: $315,8602021Assets 2022: $890,707Liabilities 2022: $495,000Net Assets 2022: $395,7072022Assets 2023: $1,031,079Liabilities 2023: $399,799Net Assets 2023: $631,2802023

Highlighted filing

2023

Assets$1,031,079
Liabilities$399,799
Net Assets$631,280

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$1.5M$1.0M$500K$0-$500KRevenue 2011: $579,134Expenses 2011: $350,603Net Income 2011: $228,5312011Revenue 2012: $652,687Expenses 2012: $659,528Net Income 2012: -$6,8412012Revenue 2013: $688,245Expenses 2013: $538,785Net Income 2013: $149,4602013Revenue 2014: $1,206,352Expenses 2014: $752,681Net Income 2014: $453,6712014Revenue 2015: $822,850Expenses 2015: $936,862Net Income 2015: -$114,0122015Revenue 2016: $1,311,399Expenses 2016: $683,030Net Income 2016: $628,3692016Revenue 2017: $772,216Expenses 2017: $534,970Net Income 2017: $237,2462017Revenue 2018: $724,013Expenses 2018: $554,311Net Income 2018: $169,7022018Revenue 2019: $613,312Expenses 2019: $795,879Net Income 2019: -$182,5672019Revenue 2020: $439,679Expenses 2020: $550,048Net Income 2020: -$110,3692020Revenue 2021: $743,798Expenses 2021: $840,616Net Income 2021: -$96,8182021Revenue 2022: $316,970Expenses 2022: $268,996Net Income 2022: $47,9742022Revenue 2023: $752,179Expenses 2023: $516,774Net Income 2023: $235,4052023

Highlighted filing

2023

Revenue$752,179
Expenses$516,774
Net Income$235,405

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2023Summary only. Only limited summary data is available for this year.$1.03$0.40$0.63$0.75$0.52$0.24
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.89$0.50$0.40$0.32$0.27$0.05
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.97$0.66$0.32$0.74$0.84$0.10
2020Summary only. Only limited summary data is available for this year.$0.89$0.49$0.40$0.44$0.55$0.11
2019Summary only. Only limited summary data is available for this year.$2.53$0.57$1.96$0.61$0.80$0.18
2018Summary only. Only limited summary data is available for this year.$2.51$0.59$1.92$0.72$0.55$0.17
2017Summary only. Only limited summary data is available for this year.$2.55$0.64$1.91$0.77$0.53$0.24
2016Summary only. Only limited summary data is available for this year.$2.46$0.79$1.67$1.31$0.68$0.63
2015Summary only. Only limited summary data is available for this year.$2.23$1.19$1.04$0.82$0.94$0.11
2014Summary only. Only limited summary data is available for this year.$2.03$0.85$1.17$1.21$0.75$0.45
2013Summary only. Only limited summary data is available for this year.$1.28$0.57$0.72$0.69$0.54$0.15
2012Summary only. Only limited summary data is available for this year.$1.09$0.52$0.57$0.65$0.66$0.01
2011Summary only. Only limited summary data is available for this year.$0.85$0.28$0.58$0.58$0.35$0.23
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2023 to Dec 31, 2023
Mission and Program Overview

Mission

To encourage and finance research of innovative cancer treatment and detection for the most difficult-to-treat and understudied cancers.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.